How CBG May Support Appetite and Metabolism: What Research Shows
CBG and Metabolic Research
A March 2026 study published in the British Journal of Pharmacology examined CBD and CBG's effects on metabolic markers. Key findings:
- CBG was more effective than CBD at reducing body fat accumulation
- CBG showed superior results for improving insulin sensitivity
- Both cannabinoids improved markers of fatty liver disease
- CBG activated PPARgamma receptors more strongly than CBD
The PPARgamma Connection
PPARgamma is a nuclear receptor that regulates fat cell formation, glucose metabolism, and insulin sensitivity. Pharmaceutical drugs that activate PPARgamma (like thiazolidinediones) are used to treat type 2 diabetes. CBG appears to activate this same receptor through a natural, non-pharmaceutical mechanism.
What This Means for Coffee Drinkers
Coffee itself has established metabolic benefits. Caffeine increases metabolic rate by 3-11% and enhances fat oxidation. Adding CBG to this equation introduces a second metabolic pathway through PPARgamma activation, potentially creating a complementary effect.
Important Caveats
This research is preclinical (conducted in animal models). Human clinical trials on CBG's metabolic effects have not been published. We report what the science shows honestly. CBG coffee is a food product, not a metabolic supplement, and should not replace medical treatment for metabolic conditions.
Leave a comment